The goal is not to become overly cautious, but simply to build a few reliable habits when it comes to handling such fragile medications like Ozempic
The reasons are structural and worth naming: income level, tax capacity, formal employment, public share of healthcare spending, and drug pricing
Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, at higher doses (as Wegovy), for weight management in adults with obesity
Request an appointment and choose telehealth or in-person
You receive physician-guided support tailored to your lifestyle and designed to encourage consistency over time
Your progress, tolerability, and individual response are continuously monitored to ensure the dosing schedule is optimized for your unique needs